Dechra Veterinary Products acquires STEM Animal Health

1 minute read
15 April 2024

On April 15, 2024, Dechra Veterinary Products, Inc. ("Dechra") completed the purchase of all the issued and outstanding shares of STEM Animal Health Inc. from Kane Biotech Inc. and Ecuphar NV (a subsidiary of Animalcare Group PLC).

This transaction will allow Dechra to continue to deliver its best-in-class Vetradent pet oral care line and also provides a significant opportunity to expand its offerings in the e-commerce and pet specialty markets in North and South America.

Dechra is an international specialist veterinary pharmaceuticals and related products business.

Gowling WLG was Canadian counsel to Dechra with respect to this transaction, with a team led by Daniel Scott and that included Jessica Ward (corporate/M&A) and John Peters and Frédéric Bolduc (employment), with the assistance of student-at-law Jay Lu.

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.